Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.8K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

237
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
237
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

349
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
349
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

395
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
395
Response Surface Methodology01:16

Response Surface Methodology

595
Response Surface Methodology (RSM) is a collection of statistical and mathematical techniques used to develop, improve, and optimize processes. It is particularly valuable when many input variables or factors potentially influence a response variable.
The process of RSM involves several key steps:
595
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

171
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
171

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV.

Antimicrobial agents and chemotherapy·2026
Same author

Correction: Randomized-Exposure Mixture-Model Analysis (REMIX) allowing Type-1 Error Controlled Exposure-Response Modelling.

The AAPS journal·2025
Same author

Cystatin C-based eGFR better predicts renal vancomycin clearance than creatinine-based eGFR in patients with allogeneic stem cell transplantation.

Clinical pharmacology and therapeutics·2025
Same author

Towards precision dosing of vancomycin in patients with allogeneic hematopoietic stem cell transplantation: a comparison of published population pharmacokinetic models.

Antimicrobial agents and chemotherapy·2025
Same author

Clinically applicable parasite viability assay for rapid assessment of antimalarial pharmacodynamic endpoints.

Antimicrobial agents and chemotherapy·2025
Same author

Interoccasion variability in population pharmacokinetic models: identifiability, influence, interdependencies and derived study design recommendations.

Journal of pharmacokinetics and pharmacodynamics·2025

Related Experiment Video

Updated: Jan 12, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.7K

Randomized-Exposure Mixture-Model Analysis (REMIX) allowing Type-1 Error Controlled Exposure-Response Modelling.

Daniel Wojtyniak1,2, Jinju Guk2, Sebastian G Wicha3

  • 1Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany.

The AAPS Journal
|October 31, 2025
PubMed
Summary
This summary is machine-generated.

A new method, Randomized-exposure mixture-model analysis with type 1 error control (REMIX), reduces incorrect conclusions from drug development models. While REMIX requires more patients in some cases, it offers better control over Type I errors compared to the standard approach.

Keywords:
NONMEM®exposure–responsemixture modelsstochastic simulation and estimationtype I error rate

More Related Videos

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.8K
Author Spotlight: Deciphering the Long-Term Effects of Low-Level Blast Exposures in Mice
06:00

Author Spotlight: Deciphering the Long-Term Effects of Low-Level Blast Exposures in Mice

Published on: May 24, 2024

1.3K

Related Experiment Videos

Last Updated: Jan 12, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.7K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.8K
Author Spotlight: Deciphering the Long-Term Effects of Low-Level Blast Exposures in Mice
06:00

Author Spotlight: Deciphering the Long-Term Effects of Low-Level Blast Exposures in Mice

Published on: May 24, 2024

1.3K

Area of Science:

  • Pharmacometrics
  • Statistical modeling in drug development
  • Quantitative systems pharmacology

Background:

  • Exposure-response models are crucial for dose optimization in drug development.
  • Model misspecification can lead to significant Type I errors (T1), resulting in costly decisions.
  • The standard approach (STA) is susceptible to T1 inflation when models are misspecified.

Purpose of the Study:

  • To introduce and evaluate a novel approach, Randomized-exposure mixture-model analysis with type 1 error control (REMIX), designed to mitigate issues arising from model misspecification.
  • To compare the performance of REMIX against the Standard Approach (STA) in terms of T1 rate control, statistical power, and parameter estimation accuracy.
  • To assess the predictive performance of both REMIX and STA.

Main Methods:

  • The study employed 82 simulation-estimation scenarios using a hypothetical antidiabetic drug.
  • Type I error rates and statistical power were evaluated under conditions of model misspecification and correct specification.
  • Predictive performance, parameter estimate accuracy, precision, and bias were assessed for both REMIX and STA.

Main Results:

  • REMIX demonstrated a lower T1 rate inflation (21/82) compared to STA (44/82), indicating improved control over false positives.
  • In scenarios with a clear drug effect and no misspecification, REMIX required more patients (27) to achieve 80% power compared to STA (17).
  • REMIX showed superior performance in scenarios with no drug effect, outperforming STA in terms of relative root mean squared error (rRMSE) and relative bias (rBias). Parameter estimate precision and accuracy were comparable between the two methods.

Conclusions:

  • REMIX offers a valuable alternative to STA for controlling Type I errors in exposure-response modeling, particularly when model misspecification is a concern.
  • While REMIX may necessitate larger sample sizes in certain situations, its improved T1 error control is a significant advantage.
  • Further research comparing REMIX with other T1 error control methods is warranted.